This inventor holds 1 USPTO granted patent. Top assignees: Mayo Foundation for Medical Education and Research, Osaka University. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2016
Title: Takuma Kamon: Innovator in Cancer Treatment
Introduction
Takuma Kamon is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds. His work focuses on addressing critical health challenges, particularly in treating brain and nervous system cancers.
Latest Patents
Kamon holds a patent for "Substituted imidazo[4',5':4,5]cyclopenta[1,2-e]pyrrolo[1,2-a]pyrazines and oxazolo[4',5':4,5]cyclopenta[1,2-e]pyrrolo[1,2-a]pyrazines for treating brain cancer." This patent relates to compounds and compositions that are useful for treating various cancers, including those affecting the brain. The compounds include a compound of Formula I or a pharmaceutically acceptable salt thereof, which demonstrates potential in cancer therapy.
Career Highlights
Throughout his career, Takuma Kamon has worked with esteemed institutions such as the Mayo Foundation for Medical Education and Research and Osaka University. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Kamon has collaborated with notable colleagues, including Han W Tun and Daisuke Shigeoka. These partnerships have enhanced his research efforts and expanded the impact of his work in cancer treatment.
Conclusion
Takuma Kamon is a dedicated inventor whose work in developing innovative compounds for cancer treatment is commendable. His contributions to the medical field highlight the importance of research and collaboration in addressing complex health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile